Research Studies

COVID-19 Vaccination and Uveitis Relapse

Scientists analyzed a group of 438 participants with a history of uveitis who received at least one dose of the COVID-19 vaccine but had no history of previous COVID-19 infection. Participants received one of the vaccines available in China, including Sinovac, Sinopharm, CanSino, and Zhifei.

Read More »

COVID-19 in Patients with Behçet’s disease

Behçet’s disease patients are usually on long-term therapy with colchicine, TNF inhibitors, or glucocorticoids; a recent study aimed to understand the prevalence of COVID-19-related clinical outcomes in Behçet’s disease patients treated with these therapies.

Read More »

Long COVID & Systemic Autoimmune Rheumatic Diseases

Those suffering from systemic autoimmune rheumatic diseases have an increased risk of severe outcomes from a COVID-19 infection. Due to factors such as altered immunity or the use of immunosuppressive medications, they may also be at risk of developing Long COVID.

Read More »
Join Our Community!Stay Informed. Stay Hopeful.

Sign up for periodic emails with resources, insights, and updates on autoimmune disease and living with chronic illness.

By adding your phone number, you agree to receive text message updates. Msg & data rates may apply.